Pharmaceutical Products for CDER Research Studies - IDIQ
Award Notice Posted
- Solicitation number
- 75F40126D00023
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Awarded
- to We Pharma, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75F40126D00023 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- North Carolina 27560, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Food and Drug Administration awarded a contract to WE PHARMA, INC. for $4 million on September 11, 2026, for pharmaceutical products supporting CDER research studies under an IDIQ vehicle.
The contract number is 75F40126D00023. The award was made under no set-aside.
Notice text
Award notice.
Awarded contract 75F40126D00023 to WE PHARMA, INC. for 4000000.00 on 2026-09-11.
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Pharmaceutical Products for CDER Research Studies - IDIQ | Solicitation | |
| Pharmaceutical Products for CDER Research Studies - IDIQ | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity